Holen Sie sich die Stockscreener-App
7.655
0.46%
-0.035
Instil Bio Inc Aktie (TIL) Neueste Nachrichten
Market Leaders: Is Instil Bio Inc gaining market shareBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
(TIL) Volatility Zones as Tactical Triggers - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, ... - Bluefield Daily Telegraph
Price-Driven Insight from (TIL) for Rule-Based Strategy - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc.TIL - yourwyominglink.com
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Shareholders to Connect - accessnewswire.com
Entry Recap: Is TROOPS Inc benefiting from interest rate changesJuly 2025 Opening Moves & Target Return Focused Stock Picks - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
TIL ALERT: Ongoing Investigation Into Instil Bio, Inc.Contact Levi & Korsinsky - TMX Newsfile
Instil Bio Faces Investigation After AXN-2510 Discontinuation, Stock Plummets 45.81% - intellectia.ai
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Stockholders to Inquire about Securities Investigation - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
(TIL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Investors to Connect - accessnewswire.com
Forecast Cut: Can Instil Bio Inc scale operations efficientlyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Instil Bio, Inc. (TIL) And Encourages Stockholders to Reach Out - accessnewswire.com
Published on: 2026-01-13 02:54:06 - ulpravda.ru
Instil Bio, Inc. (TIL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Will Instil Bio Inc. stock see PE expansionJuly 2025 Drop Watch & Fast Entry Momentum Alerts - Улправда
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Will Instil Bio Inc. stock benefit from green energy trendsMarket Risk Summary & Community Supported Trade Ideas - Улправда
Portfolio Update: Is Instil Bio Inc. stock a good choice for value investorsJuly 2025 Opening Moves & Daily Volume Surge Signals - Улправда
Citizens analyst reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com South Africa
Why analysts remain bullish on Instil Bio Inc. stockMarket Entry Points & Low Risk Trading Portfolio - Улправда
Instil Bio (TIL) Downgraded to Neutral by HC Wainwright & Co. | TIL Stock News - GuruFocus
Instil On The Slide After PD-(L)1xVEGF Exit - Citeline News & Insights
Citizens analyst reiterates Market Perform rating on Instil Bio stock - Investing.com
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M - Investing.com Nigeria
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco - TipRanks
Instil Bio Terminates License and Collaboration Agreement With ImmuneOnco Biopharmaceuticals - TradingView — Track All Markets
Instil Bio shares slide on discontinuation of lead clinical programs - Proactive financial news
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation By Investing.com - Investing.com South Africa
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation - Investing.com Canada
Instil Bio Halts Main Drug Development Program - Bitget
US Stocks Mixed; Nasdaq Gains Over 50 Points - Benzinga
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco - Fierce Biotech
Instil’s bispecific dream is over | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Instil Bio stock falls after subsidiary discontinues AXN-2510 development By Investing.com - Investing.com Canada
Instil Bio stock falls after subsidiary discontinues AXN-2510 development - Investing.com
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco - The Manila Times
Instil Bio’s Subsidiary Discontinues Clinical Development - GlobeNewswire
(TIL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
IPO Launch: How Zura Bio Limited stock valuations compare to rivalsNew Guidance & Consistent Income Trade Recommendations - moha.gov.vn
Insider Buy: How Instil Bio Inc stock performs after earningsChart Signals & Short-Term Trading Alerts - moha.gov.vn
Rally Mode: Why Instil Bio Inc. stock is favored by top institutionsJuly 2025 Review & High Accuracy Trade Alerts - Улправда
0.39%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):